Relationships between objectives sleep parameters and brain amyloid load in subjects at risk for Alzheimer's disease: the INSIGHT-preAD Study.


Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
06 09 2019
Historique:
received: 29 01 2019
revised: 10 04 2019
pubmed: 4 7 2019
medline: 9 7 2020
entrez: 4 7 2019
Statut: ppublish

Résumé

Sleep changes have been associated with increased risks of developing cognitive disturbances and Alzheimer's disease (AD). A bidirectional relation is underlined between amyloid-beta (Aß) and sleep disruptions. The sleep profile in participants at risk to develop AD is not fully deciphered. We aim to investigate sleep-wake changes with objective sleep measurements in elderly participants without cognitive impairment depending on their brain amyloid status, positive (Aß+) or negative (Aß-) based on standard absorption ratios (SUVr) positron emission tomography-florbetapir imaging. Sixty-eight participants without cognitive impairment who have accepted to be involved in the sleep ancillary study from the InveStIGation of Alzheimer's Predictors in Subjective Memory Complainers (INSIGHT-pre AD) cohort, aiming to record sleep profile based on the analyses of an ambulatory accelerometer-based assessment (seven consecutive 24-hour periods). Neuropsychological tests were performed and sleep parameters have been individualized by actigraph. Participants also underwent a magnetic resonance imaging scan to assess their hippocampal volume. Based on SUVr PET-florbetapir imaging, two groups Aß+ and Aß- were compared. Participants were divided into two groups: Aß+ (n = 24) and Aß- (n = 44). Except for the SUVr, the two subgroups were comparable. When looking to sleep parameters, increased sleep latency, sleep fragmentation (wake after sleep onset [WASO] score and awakenings) and worst sleep efficiency were associated with cortical brain amyloid load. Actigraphic sleep parameters were associated with cortical brain amyloid load in participants at risk to develop AD. The detection of sleep abnormalities in those participants may be of interest to propose some preventive strategies.

Identifiants

pubmed: 31267124
pii: 5527427
doi: 10.1093/sleep/zsz137
pii:
doi:

Substances chimiques

Amyloid beta-Peptides 0
Aniline Compounds 0
Ethylene Glycols 0
florbetapir 6867Q6IKOD

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Sleep Research Society 2019. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Auteurs

Eric Ettore (E)

Université Côte d'Azur, CoBTeK lab, Centre Mémoire de Ressources et de Recherche, Nice University Hospital France.
Department of Psychiatry, Nice University Hospital France.

Hovagim Bakardjian (H)

Institute of Memory and Alzheimer's Disease, ICM, INSERM, CNRS UMR, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University Paris, Paris, France.

Marine Solé (M)

Institute of Memory and Alzheimer's Disease, ICM, INSERM, CNRS UMR, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University Paris, Paris, France.

Marcel Levy Nogueira (M)

Institute of Memory and Alzheimer's Disease, ICM, INSERM, CNRS UMR, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University Paris, Paris, France.

Marie-Odile Habert (MO)

Nuclear Medicine Department, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University Paris, Paris, France.

Audrey Gabelle (A)

Memory Research and Resources Center for Alzheimer's disease, Department of Neurology, Montpellier University Hospital, and Inserm, and University of Montpellier, Montpellier, France.

Bruno Dubois (B)

Institute of Memory and Alzheimer's Disease, ICM, INSERM, CNRS UMR, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University Paris, Paris, France.

Philippe Robert (P)

Université Côte d'Azur, CoBTeK lab, Centre Mémoire de Ressources et de Recherche, Nice University Hospital France.

Renaud David (R)

Université Côte d'Azur, CoBTeK lab, Centre Mémoire de Ressources et de Recherche, Nice University Hospital France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH